1,791 results · 35ms · Sources: EU EUDAMED, US FDA

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent Venous RP & Endoprosthesis with Unistep Plus

Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

FDA Pre-Market Approval
FDA Class 3 ·VENTANA MMR RxDx Panel

Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

FDA Pre-Market Approval
FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Immunocytochemistry Assay, P16/Ki-67

FDA Pre-Market Approval
FDA Class 3 ·CINtec PLUS Cytology

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT (TIPS,ILAC,VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT ENDOPROSTHESIS (VENOUS)

Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

FDA Pre-Market Approval
FDA Class 3 ·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent (Venous) Endoprosthesis with Unisteo Plus Delivery System

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT (VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent Venous Endoprosthesis with Unistep Plus™ Delivery System

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·Wallstent Venous Endoprosthesis with UNISTEP Plus

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT ENDO (VENOUS) STENT SYTEM

Immunocytochemistry Assay, P16/Ki-67

FDA Pre-Market Approval
FDA Class 3 ·CINtec PLUS Cytology

Immunocytochemistry Assay, P16/Ki-67

FDA Pre-Market Approval
FDA Class 3 ·CINtec PLUS Cytology

Stent, Central Venous

FDA Pre-Market Approval
FDA Class 3 ·WALLSTENT ENDOPROSTHESIS VENOUS